Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression is a research paper published in Immunogenetics (2023). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: GM075091
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: AI157850
SANTHE
Grant: DEL-15-006
Frederick National Laboratory for Cancer Research
Grant: HHSN261200800001E
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2012/18010-0
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2013/22007-7
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2014/12123-2
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2016/24734-1
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: 470043/2014-8
NIGMS NIH HHS
Grant: R01 GM075091
NIAID NIH HHS
Grant: R56 AI150371
NIAID NIH HHS
Grant: R01 AI157850
National Institutes of Health
Grant: 5R01GM075091-10
Theoretical Population Genetics
National Institutes of Health
Grant: 1R01AI157850-01A1
Role of cellular long non-coding RNAs in HIV replication and disease outcome
South African Medical Research Council
FWCI
4.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 1 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 7 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 9 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 7 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 8 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 8 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 9 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 6 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 5 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 5 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 6 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 3 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 4 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 2 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 3 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 4 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
Additional file 2 of Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer